News for Kiromic BioPharma, Inc. (KRBP)

Kiromic BioPharma Reports Favorable 10-Month Follow-Up Results for the First Patient Treated in its Deltacel-01 Clinical Trial

Kiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical Trial

Kiromic BioPharma Reports Favorable Results at Six Weeks from Fourth Patient in Deltacel-01 Clinical Trial

Scans of this first patient in the second cohort show 8.5% reduction in tumor size ...

March 20, 2024 (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces today's roundup of stocks to watch ...

Live and Archived Fireside Chat Available at VirtualInvestorConferences.com

Second Patient Completed Treatment and Third Patient Dosed in Phase 1 Study Evaluating Deltacel™ for the Treatment of Non-Small Cell Lung Cancer ...

MINNEAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and...

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition...

The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET)..

NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) -- First Miami Bancorp, Inc. (OTC: FMIA) Lifshitz Law PLLC announces an investigation into possible...

Read Reviewing Clarus Therapeutics (NASDAQ:CRXT) and Kiromic BioPharma (NASDAQ:KRBP) at ETF Daily News

Read Research Analysts’ Downgrades for May 25th (AAALF, ACLS, ADSK, ALK, ASGN, AXTA, BBY, CNS, CVET, DVN) at ETF Daily News

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

Gainers

During Thursday's morning trading, 152 companies set new 52-week lows. Noteworthy Points From Today's 52-Week Lows: Rivian Automotive ...